Skip to Content

Susan L Tucker, Ph.D.

Present Title & Affiliation

Primary Appointment

Deputy Department Chair, Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor (tenured), Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1400 Pressler Street
Unit Number: 1410
Houston, TX 77030
Room Number: FCT4.5004
Phone: 713-792-2613
Fax: 713-563-4242

Education & Training

Degree-Granting Education

1980 University of Michigan, Ann Arbor, MI, PHD, Mathematics
1977 University of Michigan, Ann Arbor, MI, MA, Mathematics
1974 Smith College, Northampton, MA, AB, Mathematics

Postgraduate Training

3/2004-3/2005 Faculty Leadership Academy (Cohort IV), The University of Texas MD Anderson Cancer Center, Houston, TX

Experience/Service

Other Appointments/Responsibilities

Faculty Member, Graduate School of Biomedical Sciences, Houston, TX, 6/1988-present

Honors and Awards

2002 BPW/Texas Award for Outstanding Leadership in Cancer Research, Texas Federation of Business and Professional Women's Clubs, Inc.
1983 Young Investigator Award, 7th International Congress of Radiation Research
1978 Rackham Travel Grant, University of Michigan
1974 Summa cum laude graduate, Smith College
1973 Phi Beta Kappa, Smith College
1973 Sigma Xi, Smith College

Selected Publications

Peer-Reviewed Original Research Articles

1. Tucker SL, Liao Z, Dinh J, Bian SX, Mohan R, Martel MK, Grosshans DR. Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort. In Press.
2. Wang J, Wei C, Tucker SL, Myles B, Palmer M, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z, Lin SH. Predictors of Postoperative Complications after Trimodality Therapy for Esophageal Cancer 86(5):885-891, 8/2013.
3. Park PC, Cheung JP, Zhu R, Lee AK, Sahoo N, Tucker SL, Liu W, Li H, Mohan R, Court LE, Dong L. Statistical Assessment of Proton Treatment Plans under Setup and Range Uncertainties. int J Radiat Oncol Biol Phys 86(5):1007-1013, 8/2013.
4. Brown AP, Barney CL, Grosshans DR, McAleer MF, deGroot JF, Puduvalli VK, Tucker SL, Crawford CN, Khan M, Khatua S, Gilbert MR, Brown PD, Mahajan A. Proton Beam Craniospinal Irradiation Reduces Acute Toxicity for Adults with Medulloblastoma. Int J Radiat Oncol Biol Phys 86(2):277-284, 6/2013.
5. Yuan X, Wei Q, Komaki R, Liu Z, Yang J, Tucker SL, Xu T, Heymach JV, Lu C, Cox, JD, Liao Z. TGFB1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy 8(6):e65659, 6/2013. e-Pub 6/2013.
6. Vinogradskiy V, Castillo R, Castillo E, Tucker SL, Liao Z, Guerrero T, Martel MK. Use of 4-dimensional computed tomography-based ventilation imaging to correlate lung dose and function with clinical outcomes. Int J Radiat Oncol Biol Phys 86(2):366-371, 6/2013.
7. Olsson C, Pettersson N, Alsadius D, Wilderang U, Tucker SL, Johansson KA, Steineck G. Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy. Br J Cancer 108:1964-1970, 4/2013.
8. Mittendorf EA, Buchholz TA, Tucker SL, Meric-Bernstam F, Kuerer HM, Gonzalez-Angulo AM, Bedrosian I, Babiera GV, Hoffman K, Yi M, Ross MI, Hortobagyi GN, Hunt KK. Impact of Chemotherapy Sequencing on Local-Regional Failures in Breast Cancer Patients Undergoing Breast Conserving Therapy. Annals Surg 257(2):173-179, 2/2013.
9. Tsai CJ, Hofstede TM, Sturgis EM, Garden AS, Lindberg ME, Wei Q, Tucker SL, Dong L. Osteoradionecrosis and Radiation Dose to the Mandible in Patients With Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys 85(2):415-420, 2/2013. e-Pub 7/2012. PMID: 22795804.
10. Tucker SL, Mohan R, Liengsawangwong R, Martel MK, Liao Z. Predicting Pneumonitis Risk: A Dosimetric Alternative to Mean Lung Dose. Int J Radiat Oncol Biol Phys 85(2):522-527, 2/2013. e-Pub 5/2012. PMID: 22580121.
11. Tucker SL, Li M, Xu T, Gomez D, Yuan X, Yu J, Liu Z, Yin M, Guan X, Wang LE, Wei Q, Mohan R, Vinogradskiy Y, Martel M, Liao Z. Incorporating Single Nucleotide Polymorphisms into the Lyman Model to Improve Prediction of Radiation Pneumonitis. Int J Radiat Oncol Biol Phys 85(1):251-257, 1/2013. e-Pub 4/2012. PMID: 22541966.
12. Pettersson, Olsson C, Tucker SL, Alsadius D, Wilderang U, Johansson KA, Steineck G. Urethral pain among prostate cancer survivors 1 to 14 years after radiation therapy. Int J Radiat Oncol Biol Phys 85(1):e29-e37, 1/2013.
13. Court LE, Tucker SL, Gomez D, Liao Z, Zhang J, Kry S, Dong L, Martel MK. A Technique to use CT Images for In Vivo Detection and Quantification of the Spatial Distribution of Radiation-Induced Esophagitis. Journal of Applied Clinical Medical Physics 14(3):91-98, 2013.
14. Gomez DR, Tucker SL, Martel MK, Mohan R, Balter PA, Lopez Guerra JL, Liu H, Komaki R, Cox JD, Liao Z. Predictors of High-grade Esophagitis After Definitive Three-dimensional Conformal Therapy, Intensity-modulated Radiation Therapy, or Proton Beam Therapy for Non-small cell Lung Cancer. Int J Radiat Oncol Biol Phys 84(4):1010-1016, 11/2012. e-Pub 8/2012. PMID: 22920974.
15. Vinogradskiy Y, Tucker SL, Bluett JB, Wages CA, Liao Z, Martel MK. Prescribing radiation dose to lung cancer patients based on personalized toxicity estimates. J Thorac Oncol 7(11):1676-1682, 11/2012.
16. Tucker SL, Dong L, Michalski JM, Bosch WR, Winter K, Cox JD, Purdy JA, Mohan R. Do Intermediate Radiation Doses Contribute to Late Rectal Toxicity? An Analysis of Data from Radiation Therapy Oncology Group Protocol 94-06. Int J Radiat Oncol Biol Phys 84(2):390-5, 10/1/2012. e-Pub 2/17/2012. PMID: 22342302.
17. Waldenström AC, Olsson C, Wilderäng U, Dunberger G, Lind H, Alevronta E, Al-Abany M, Tucker S, Avall-Lundqvist E, Johansson KA, Steineck G. Relative importance of hip and sacral pain among long-term gynecological cancer survivors treated with pelvic radiotherapy and their relationships to mean absorbed doses. Int J Radiat Oncol Biol Phys 84(2):428-436, 10/1/2012. e-Pub 2/24/2012. PMID: 22365620.
18. Tucker SL, Michalski JM, Bosch WR, Mohan R, Dong L, Winter K, Purdy JA, Cox JD. Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06. Radiother Oncol 104(1):109-113, 7/2012. e-Pub 6/5/2012. PMCID: PMC3413409.
19. Jiang ZQ, Yang K, Komaki R, Wei X, Tucker SL, Zhuang Y, Martel MK, Vedam S, Balter P, Zhu G, Gomez D, Lu C, Mohan R, Cox JD, Liao Z. Long Term Clinical Outcome of Intensity-Modulated Radiotherapy for Inoperable Non-Small Cell Lung Cancer: The MD Anderson Experience. Int J Radiat Oncol Biol Phys 83(1):332-339, 5/1/2012. e-Pub 11/11/2011. PMID: 22079735.
20. Vinogradskiy Y, Tucker SL, Liao Z, Martel MK. Investigation of the Relationship Between Gross Tumor Volume Location and Pneumonitis Rates Using a Large Clinical Database of Non-Small-Cell Lung Cancer Patients. Int J Radiat Oncol Biol Phys 82(5):1650-1658, 4/1/2012. e-Pub 4/15/2011. PMID: 21497454.
21. Akli S, Zhang XQ, Bondaruk J, Tucker SL, Czerniak PB, Benedict WF, Keyomarsi K. Low-molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage, and invasive bladder cancer. Cell Cycle 11(7):1468-1476, 4/1/2012. e-Pub 4/1/2012. PMCID: PMC3350882.
22. Vinogradskiy Y, Tucker SL, Liao Z, Martel MK. A Novel Method to Incorporate the Spatial Location of the Lung Dose Distribution into Predictive Radiation Pneumonitis Modeling. Int J Radiat Oncol Biol Phys 82(4):1549-1555, 3/15/2012. e-Pub 7/6/2011. PMID: 21741183.
23. Wu Y, Mittendorf EA, Kelten C, Tucker SL, Wei W, Middleton LP, Broglio K, Buchholz TA, Hunt KK, Sahin AA. Occult Axillary Lymph Node Metastases Do Not Have Prognostic Significance in Early Stage Breast Cancer. Cancer 118(6):1507-1514, 3/15/2012. e-Pub 8/25/2011. PMID: 22009292.
24. Akay CL, Meric-Bernstam F, Hunt KK, Grubbs EG, Bedrosian I, Tucker SL, Kuerer HM, Hoffman KE, Babiera GV, Strom EA, Buchholz TA, Mittendorf EA. Evaluation of the MD Anderson Prognostic Index for Local-Regional Recurrence after Breast Conserving Therapy in Patients Receiving Neoadjuvant Chemotherapy. Ann Surg Oncol 19(3):901-907, 3/2012. e-Pub 8/23/2011. PMID: 21861223.
25. Caudle AS, Yu TK, Tucker SL, Bedrosian I, Litton JK, Gonzalez-Angulo AM, Hoffman K, Meric-Bernstam F, Hunt KK, Buchholz TA, Mittendorf EA. Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy. Breast Cancer Res 14(3):R83, 2012. e-Pub 5/23/2012. PMCID: PMC3446346.
26. Tucker SL, Thames HD, Michalski JM, Bosch WR, Mohan R, Winter K, Cox JD, Purdy JA, Dong L. Estimation of a/ß for Late Rectal Toxicity Based on RTOG 94-06. Int J Radiat Oncol Biol Phys 81(2):600-5, 10/2011. e-Pub 3/2011. PMCID: PMC3163802.
27. Woodward WA, Gao H, Cohen E, Li L, Xu W, Debeb BG, Jimenez CA, Krishnamurthy S, Tucker SL, Hortobagyi GN, Cristofanilli M, Buchholz TA, Reuben JM. Percentage of CD45- CD326+ CD44+CD24-/lo cells in pleural effusion fluid of patients with metastatic breast cancer predicts for overall survival. Interventional Oncology 1(1):4-10, 8/2011.
28. Mittendorf EA, Jeruss JS, Tucker SL, Kolli A, Newman LA, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol 29(15):1956-62, 5/20/2011. e-Pub 4/11/2011. PMCID: PMC3107758.
29. Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Tereffe W, Woodward WA, Strom EA, Hunt KK, Tucker SL, Buchholz TA. Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer. Cancer 117(8):1595-601, 4/2011. e-Pub 11/2010. PMID: 21472707.
30. Schwartz DL, Hutcheson K, Barringer D, Tucker SL, Kies M, Holsinger FC, Ang KK, Morrison WH, Rosenthal DI, Garden AS, Dong L, Lewin JS. Candidate Dosimetric Predictors of Long-Term Swallowing Dysfunction After Oropharyngeal Intensity-Modulated Radiotherapy. Int J Radiat Oncol Biol Phys 78(5):1356-1365, 12/2010. e-Pub 6/2010. PMID: 20646872.
31. Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Mohan R, Purdy JA, Kuban D, Lee AK, Cheung MR, Thames HD, Cox JD. Late Rectal Toxicity on RTOG 94-06: Analysis using a Mixture Lyman Model. Int J Radiat Oncol Biol Phys 78(4):1253-60, 11/15/2010. e-Pub 7/2/2010. PMCID: PMC2963659.
32. Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Strom EA, Tereffe W, Woodward WA, Tucker SL, Hunt KK, Hortobagyi GN, Buchholz TA. Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer. Int J Radiat Oncol Biol Phys 77(5):1296-302, 8/2010. e-Pub 5/2010. PMID: 20472353.
33. Mittendorf EA, Liu Y, Tucker SL, McKenzie T, Qiao N, Akli S, Biernacka A, Liu Y, Meijer L, Keyomarsi K, Hunt KK. A Novel Interaction Between HER2/neu and Cyclin E in Breast Cancer. Oncogene 29(27):3896-3907, 7/8/2010. e-Pub 5/10/2010. PMCID: PMC2900397.
34. Tucker SL, Jin H, Wei X, Wang S, Martel MK, Komaki R, Liu HH, Mohan R, Chen Y, Cox JD, Liao Z. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys 77(3):691-698, 7/2010. PMID: 19836159.
35. Frank SJ, Kudchadker RJ, Kuban DA, De Crevoisier R, Lee AK, Cheung RM, Choi S, Tucker SL, Dong L. A Volumetric Trend Analysis of the Prostate and Seminal Vesicles During a Course of Intensity-Modulated Radiation Therapy. Am J Clin Oncol 33(2):173-175, 4/2010. PMID: 20010077.
36. Liao ZX, Komaki RR, Thames HD, Liu HH, Tucker SL, Mohan R, Martel MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys 76(3):775-81, 3/1/2010. e-Pub 6/8/2009. PMID: 19515503.
37. Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 76(3 Suppl):S123-9, 3/2010. PMID: 20171506.
38. Akli S, Bui T, Wingate H, Biernacka A, Moulder S, Tucker SL, Hunt KK, Keyomarsi K. Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors. Clin Cancer Res 16(4):1179-90, 2/15/2010. e-Pub 2/9/2010. PMCID: PMC2822889.
39. Nelson C, Balter P, Morice RC, Bucci K, Dong L, Tucker S, Vedam S, Chang JY, Starkschall G. Evaluation of tumor position and PTV margins using image guidance and respiratory gating. Int. J. Radiation Oncology Biol. Phys 76(5):1578-1585, 2010.
40. Yuan X, Liao Z, Liu Z, Wang LE, Tucker SL, Mao L, Wang XS, Martel M, Komaki R, Cox JD, Milas L, Wei Q. Single Nucleotide Polymorphism at rs1982073:T869C of the TGF{beta}1 Gene Is Associated With the Risk of Radiation Pneumonitis in Patients With Non-Small-Cell Lung Cancer Treated With Definitive Radiotherapy. J Clin Oncol 27(20):3370-78, 7/2009. e-Pub 4/2009. PMID: 19380441.
41. Jin H, Tucker SL, Liu HH, Wei X, Yom SS, Wang S, Komaki R, Chen Y, Martel MK, Mohan R, Cox JD, Liao Z. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol 91(3):427-32, 6/2009. e-Pub 10/2008. PMID: 18937989.
42. Gilcrease MZ, Woodward WA, Nicolas MM, Corley LJ, Fuller GN, Esteva FJ, Tucker SL, Buchholz TA. Even Low-Level HER2 Expression May be Associated with Worse Outcome in Node-positive Breast Cancer. Am J Surg Pathol 33(5):759-767, 5/2009. PMID: 19252432.
43. Wingate H, Puskas A, Duong M, Bui T, Richardson D, Liu Y, Tucker SL, Van Pelt C, Meijer L, Hunt K, Keyomarsi K. Low Molecular Weight Cyclin E is Specific in Breast Cancer and is Associated with Mechanisms of Tumor Progression. Cell Cycle 8(7):1062-8, 4/1/2009. e-Pub 4/10/2009. PMCID: PMC2692060.
44. Beadle BM, Woodward WA, Tucker SL, Outlaw ED, Allen PK, Oh JL, Strom EA, Perkins GH, Tereffe W, Yu TK, Meric-Bernstam F, Litton JK, Buchholz TA. Ten-year Recurrence Rates in Young Women with Breast Cancer by Locoregional Treatment Approach. Int J Radiat Oncol Biol Phys 73(3):734-744, 3/1/2009. e-Pub 8/15/2008. PMCID: PMC3041273.
45. Gilcrease MZ, Kilpatrick SK, Woodward WA, Zhou X, Nicolas MM, Corley LJ, Fuller GN, Tucker SL, Diaz LK, Buchholz TA, Frost JA. Coexpression of {alpha}6{beta}4 Integrin and Guanine Nucleotide Exchange Factor Net1 Identifies Node-Positive Breast Cancer Patients at High Risk for Distant Metastasis. Cancer Epidemiol Biomarkers Prev 18(1):80-6, 1/2009. PMCID: PMC2669542.
46. Eifel PJ, Jhingran A, Levenback CF, Tucker S. Predictive value of a proposed subclassification of stages I and II cervical cancer based on clinical tumor diameter. Int J Gynecol Cancer 19(1):2-7, 1/2009. PMID: 19258933.
47. Mittendorf EA, Sahin AA, Tucker SL, Meric-Bernstam F, Yi M, Nayeemuddin KM, Babiera GV, Ross MI, Feig BW, Kuerer HM, Hunt KK. Lymphovascular Invasion and Lobular Histology are Associated with Increased Incidence of Isolated Tumor Cells in Sentinel Lymph Nodes from Early Stage Breast Cancer Patients. Ann Surg Oncol 15(2):3369-3377, 12/2008. e-Pub 9/25/2008. PMID: 18815841.
48. Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN and Hunt KK. Staging of Breast Cancer in the Neoadjuvant Setting. Cancer Research 68(16):6477-6481, 8/2008. PMID: 18701468.
49. Frank SJ, Dong L, Kudchadker RJ, De Crevoisier R, Lee AK, Cheung R, Choi S, O'Daniel J, Tucker SL, Wang H, Kuban DA. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys 71(3):813-20, 7/1/2008. e-Pub 1/22/2008. PMID: 18207664.
50. O'Daniel JC, Dong L, Zhang L, Wang H, Tucker SL, Kudchadker RJ, Lee AK, Cheung R, Cox JD, Kuban DA, Mohan R. Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy. Int J Radiat Oncol Biol Phys 71(1):274-80, 5/2008. PMID: 18406891.
51. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu C, Ajani JA, Phan A, Swisher SG, Mohan R, Cox JD, Komaki R. Association between Systemic Chemotherapy before Chemoradiation and Increased Risk of Treatment-Related Pneumonitis in Esophageal Cancer Patients Treated with Definitive Chemoradiotherapy. Journal of Thoracic Oncology 3(3):277-282, 3/2008. PMID: 18317071.
52. Wei X, Liu HH, Tucker SL, Wang S, Mohan R, Cox JD, Komaki R, Liao Z. Risk Factors for Pericardial Effusion in Inoperable Esophageal Cancer Patients Treated with Definitive Chemoradiation Therapy. Int J Radiat Oncol Biol Phys 70(3):707-14, 3/2008. PMID: 18191334.
53. Kuban D, Tucker S, Dong L, Starkschall G, Huang E, Cheung R, Lee A, Pollack A. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70(1):67-74, 1/2008. PMID: 17765406.
54. Woodward WA, Durand JB, Tucker SL, Strom EA, Perkins GH, Oh J, Arriaga L, Domain D, Buchholz TA. Prospective analysis of carotid artery flow in breast cancer patients treated with supraclavicular irradiation 8 or more years previously: no increase in ipsilateral carotid stenosis after radiation noted. Cancer 112(2):268-73, 1/2008. PMID: 18000801.
55. Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KK. The combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. J Clinical Oncology 26(2):249-52, 1/2008. PMID: 18056680.
56. Nelson C, Balter P, Morice RC, Choi B, Kudchadker RJ, Bucci K, Chang JY, Dong L, Tucker S, Vedam S, Briere T, Starkschall G. A technique for reducing patient setup uncertainties by aligning and verifying daily positioning of a moving tumor using implanted fiducials. J Appl Clin Med Phys 9(4):2766, 2008. PMID: 19020478.
57. Tucker SL, Liu HH, Liao Z, Wei X, Wang S, Jin H, Komaki R, Martel MK, Mohan R. Analysis of Radiation Pneumonitis Risk Using a Generalized Lyman Model. Int. J. Radiation Oncology Biol. Phys. 72(2):568-578, 2008.
58. Klopp AH, Chang JY, Tucker SL, Balter PA, Liu HH, Bucci MK, Macapinlac HA, Komaki R, Cox JD. Intrathoracic Patterns of Failure for Non-small-cell Lung Cancer with Positron-emission Tomography/Computed Tomography-defined Target Delineation. Int J Radiat Oncol Biol Phys 69(5):1409-16, 12/2007. PMID: 17904303.
59. Melancon AD, O'Daniel J, Zhang L, Kuban DA, de Crevoisier R, Lee AK, Cheung RM, Tucker SL, Kudchadker RJ, Newhauser WD, Mohan R, Dong L. Is a 3-MM Intra-fractional Margin Sufficient for Daily Image-guided Intensity-modulated Radiation Therapy of Prostate Cancer? Radiotherapy and Oncology 85:251-9, 12/2007.
60. de Crevoisier R, Melancon A, Kuban DA, Lee AK, Cheung R, Tucker SL, Kudchadker RJ, Newhauser W, Mohan R, Dong L. Changes in pelvic anatomy after an IMRT treatment fraction of prostate cancer. Int J Radiat Oncol Biol Phys 68 (5):1529-36, 8/2007. PMID: 17544595.
61. Bedrosian I, Lee C, Tucker SL, Palla SL, Lu K, Keyomarsi K. Cyclin E-associated kinase activity predicts response to platinum-based chemotherapy. Clin Cancer Res 13(16):4800-6, 8/2007. PMID: 17699858.
62. Akli S, Van Pelt C, Bui T, Multani A, Chang S, Johnson D, Tucker SL, Keyomarsi K. Overexpression of the low-molecular-weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway. Cancer Research 67 (15):7212-22, 8/2007. PMID: 17671189.
63. Britton KR, Starkschall G, Tucker SL, Pan T, Nelson C, Chang JY, Cox JD, Mohan R, Komaki R. Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 68(4):1036-46, 7/2007. PMID: 17379442.
64. McGuire SE, Gonzalez-Angulo AM, Huang EH, Tucker SL, Kau SC, Yu T, Strom EA, Oh JL, Woodward WA, Tereffe W, Hunt KK, Kuerer HM, Sahin AA, Hortobagyi GN, Buchholz TA. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 68(4):1004-9, 7/2007. PMID: 17418973.
65. Geara FB, Nasr E, Tucker SL, Charafeddine M, Dabaja B, Eid T, Abbas J, Salem Z, Shamseddine A, Issa P, El Saghir N. Breast cancer patients with 10 or more involved axillary lymph nodes treated by multimodality therapy: influence of clinical presentation on outcome. Int J Radiat Oncol Biol Phys 68(2):364-9, 6/2007. PMID: 17324529.
66. Middleton LP, Perkins GH, Tucker SL, Sahin AA, Singletary SE. Expression of ER(alpha) and ER(beta) in lobular carcinoma in situ. Histopathology 50 (7):875-80, 6/2007. PMID: 17543077.
67. Yom SS, Liao, Z, Liu HH, Tucker SL, Hu C, Wei X, Wang X, Wang S, Mohan R, Cox JD, Komaki R. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 68(1):94-102, 5/2007. PMID: 17321067.
68. Cheung MR, Tucker SL, Dong L, de Crevoisier R, Lee AK, Frank S, Kudchadker RJ, Thames H, Mohan R, Kuban D. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 67(4):1059-65, 3/2007. PMID: 17241755.
69. Vance W, Tucker SL, de Crevoisier R, Kuban DA, Cheung MR. The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome. Int J Radiat Oncol Biol Phys 67(3):828-33, 3/2007. PMID: 17161554.
70. Woodward WA, Huang EH, McNeese MD, Perkins GH, Tucker SL, Strom EA, Middleton L, Hahn K, Hortobagyi GN, Buchholz TA. African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy. Cancer 107(11):2662-8, 12/2006. PMID: 17061247.
71. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu C, Mohan R, Cox JD, Komaki R. Analysis of clinical and dosimetric factors associated with treatment-radiation pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66(5):1399-407, 12/2006. PMID: 16997503.
72. Tucker SL, Liu HH, Wang S, Wei X, Liao Z, Komaki R, Cox JD, Mohan R. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 66(3):754-61, 11/2006. PMID: 16965865.
73. O'Daniel JC, Dong L, Zhang L, de Crevoisier R, Wang H, Lee AK, Cheung R, Tucker SL, Kudchadker RJ, Bonnen MD, Cox JD, Mohan R, and Kuban DA. Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 66(3):883-91, 11/2006. PMID: 17011461.
74. Cheung R, Tucker SL, Kuban DA. First-year PSA kinetics and minima after prostate cancer radiotherapy are predictive of overall survival. Int J Radiat Oncol Biol Phys 66(1):20-4, 9/2006. PMID: 16814948.
75. Wei X, Liu HH, Tucker SL, Liao Z, Hu C, Mohan R, Cox JD, and Komaki R. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66(1):100-7, 9/2006. PMID: 16839700.
76. Munshi A, Tanaka T, Hobbs ML, Tucker SL, Richon VM, Meyn RE. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci. Mol Cancer Ther 5(8):1967-74, 8/2006. PMID: 16928817.
77. Chi PC, Hogstrom KR, Starkschall G, Boyd RA, Tucker SL, Antolak JA. Application of the electron pencil beam redefinition algorithm to electron arc therapy. Med Phys 33(7):2369-83, 7/2006. PMID: 16898439.
78. Tucker SL, Zhang M, Dong L, Mohan R, Kuban D, Thames HD. Cluster model analysis of late rectal bleeding after IMRT of prostate cancer:a case-control study. Int J Radiat Oncol Biol Phys 64(4):1255-64, 3/2006. PMID: 16504763.
79. Wang SL, Liao Z, Vaporciyan AA, Tucker SL, Liu H, Wei X, Swisher S, Ajani JA, Cox JD, Komaki R. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64(3):692-9, 3/2006. PMID: 16242257.
80. Chandra A, Guerrero TM, Liu HH, Tucker SL, Liao Z, Wang X, Murshed H, Bonnen MD, Garg AK, Stevens CW, Chang JY, Jeter MD, Mohan R, Cox JD, Komaki R. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol 77(3):247-53, 12/2005. PMID: 16298001.
81. Gonzalez-Angulo AM, McGuire SE, Buchholz TA, Tucker SL, Kuerer HM, Rouzier R, Kau SW, Huang EH, Morandi P, Ocana A, Cristofanilli M, Valero V, Buzdar AU, Hortobagyi GN. Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy. J Clin Oncol 23(28):7098-104, 10/2005. PMID: 16192593.
82. Ha CS, Cabanillas F, Lee MS, Tucker SL, McLaughlin P, Rodriguez MA, Younes A, Romaguera JE, Mesina OM, Cox JD. A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma. Int J Radiat Oncol Biol Phys 63(1):188-93, 9/2005. PMID: 16111588.
83. Cheung R, Kamat AM, de Crevoisier R, Allen PK, Lee AK, Tucker SL, Pisters L, Babaian RJ, Kuban D. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy. Int J Radiat Oncol Biol Phys 63(1):134-40, 9/2005. PMID: 16111581.
84. Munshi A, Kurland JF, Nishikawa T, Tanaka T, Hobbs ML, Tucker SL, Ismail S, Stevens C, Meyn RE. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. Clin Cancer Res 11(13):4912-22, 7/2005. PMID: 16000590.
85. de Crevoisier R, Tucker SL, Dong L, Mohan R, Cheung R, Cox JD, Kuban DA. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62(4):965-73, 7/2005. PMID: 15989996.
86. Ahamad A, D'Souza W, Salehpour M, Iyer R, Tucker SL, Jhingran A, Eifel PJ. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size. Int J Radiat Oncol Biol Phys 62(4):1117-24, 7/2005. PMID: 15990017.
87. Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Hortobagyi GN, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Buchholz TA. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 62(2):351-7, 6/2005. PMID: 15890574.
88. Kawase K, Dimaio DJ, Tucker SL, Buchholz TA, Ross MI, Feig BW, Kuerer HM, Meric-Bernstam F, Babiera G, Ames FC, Singletary SE, Hunt KK. Paget's disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol 12(5):391-7, 5/2005. PMID: 15915373.
89. Geara FB, Nasr E, Tucker SL, Brihi E, Zaytoun G, Hadi U, Salem Z, El Saghir N, Issa P, Shamseddine A. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center. Int J Radiat Oncol Biol Phys 61(5):1408-15, 4/2005. PMID: 15817344.
90. Cheung R, Tucker SL, Lee AK, de Crevoisier R, Dong L, Kamat A, Pisters L, Kuban D. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 61(4):993-1002, 3/2005. PMID: 15752878.
91. Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El-Naggar AK, Prieto VG, Altamirano E, Tucker SL, Strom SS, Kripke ML, Lippman SM. Mortality risk from squamous cell skin cancer. J Clin Oncol 23(4):759-65, 2/2005. PMID: 15681519.
92. Cheung R, Tucker SL, Lee AL, Dong L, Kamat A, Pisters L, Kuban DA. Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 61(1):14-9, 1/2005. PMID: 15629589.
93. Tucker SL, Dong L, Cheung R, Johnson J, Mohan R, Huang EH, Liu HH, Thames HD, Kuban D. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. Int J Radiat Oncol Biol Phys 60(5):1589-601, 12/2004. PMID: 15590191.
94. Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 101(12):2727-36, 12/2004. PMID: 15526319.
95. Butler LE, Forster KM, Stevens CW, Bloch C, Liu HH, Tucker SL, Komaki R, Liao Z, Starkschall G. Dosimetric benefits of respiratory gating: a preliminary study. J Appl Clin Med Phys 5(1):16-24, 12/2004. e-Pub 1/2004. PMID: 15753930.
96. Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 22(23):4691-9, 12/2004. PMID: 15570071.
97. Starkschall G, Forster KM, Kitamura K, Cardenas A, Tucker SL, Stevens CW. Correlation of gross tumor volume excursion with potential benefits of respiratory gating. Int J Radiat Oncol Biol Phys 60(4):1291-7, 11/2004. PMID: 15519802.
98. Andratschke NH, Nieder C, Price RE, Rivera B, Tucker SL, Ang KK. Modulation of rodent spinal cord radiation tolerance by administration of platelet-derived growth factor. Int J Radiat Oncol Biol Phys 60(4):1257-63, 11/2004. PMID: 15519798.
99. Thames HD, Zhang M, Tucker SL, Liu HH, Dong L, Mohan R. Cluster models of dose-volume effects. Int J Radiat Oncol Biol Phys 59(5):1491-504, 8/2004. PMID: 15275737.
100. Weinberg R, Kaurin DG, Choy H, Curran WJ, Jr, MacRae R, Kim JS, Kim J, Tucker SL, Bonomi PD, Belani C, Starkschall G. Dosimetric uncertainties of three-dimensional dose reconstruction from two-dimensional data in a multi-institutional study. J Appl Clin Med Phys 5(4):15-28, 8/2004. PMID: 15738918.
101. Barker JL, Garden AS, Ang KK, O'Daniel JC, Wang H, Court LE, Morrison WH, Rosenthal DI, Chao KS, Tucker SL, Mohan R, Dong L. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 59(4):960-70, 7/2004. PMID: 15234029.
102. Tucker SL, Cheung R, Dong L, Liu HH, Thames HD, Huang EH, Kuban D, Mohan R. Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 59(2):353-65, 6/2004. PMID: 15145148.
103. Garg AK, Strom EA, McNeese MD, Buzdar AU, Hortobagyi GN, Kuerer HM, Perkins GH, Singletary SE, Hunt KK, Sahin A, Schechter N, Valero V, Tucker SL, Buchholz TA. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 59(1):138-45, 5/2004. PMID: 15093909.
104. Akli S, Zheng PJ, Multani AS, Wingate HF, Pathak S, Zhang N, Tucker SL, Chang S, Keyomarsi K. Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. Cancer Res 64(9):3198-208, 5/2004. PMID: 15126360.
105. Cheung R, Tucker SL, Ye JS, Dong L, Liu H, Huang E, Mohan R, Kuban D. Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 58(5):1513-9, 4/2004. PMID: 15050331.
106. Komaki R, Lee JS, Milas L, Lee HK, Fossella FV, Herbst RS, Allen PK, Liao Z, Stevens CW, Lu C, Zinner RG, Papadimitrakopoulou VA, Kies MS, Blumenschein GR, Pisters KM, Glisson BS, Kurie J, Kaplan B, Garza VP, Mooring D, Tucker SL, Cox JD. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 58(5):1369-77, 4/2004. PMID: 15050312.
107. Murshed H, Liu HH, Liao Z, Barker JL, Wang X, Tucker SL, Chandra A, Guerrero T, Stevens C, Chang JY, Jeter M, Cox JD, Komaki R, Mohan R, Change JY. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58(4):1258-67, 3/2004. PMID: 15001271.
108. O'Daniel JC, Dong L, Kuban DA, Liu H, Schechter N, Tucker SL, Rosen I. The delivery of IMRT with a single physical modulator for multiple fields: a feasibility study for paranasal sinus cancer. Int J Radiat Oncol Biol Phys 58(3):876-87, 3/2004. PMID: 14967445.
109. Ha CS, Lee MS, McLaughlin P, Tucker SL, Wilder RB, Cox JD, Cabanillas F. Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21). Cancer J 10(1):49-53, Jan-Feb, 1/2004. PMID: 15000495.
110. Lee HK, Vaporciyan AA, Cox JD, Tucker SL, Putnam JB, Ajani JA, Liao Z, Swisher SG, Roth JA, Smythe WR, Walsh GL, Mohan R, Liu HH, Mooring D, Komaki R. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys 57(5):1317-22, 12/2003. PMID: 14630268.
111. Ha CS, Kong JS, McLaughlin P, Tucker SL, Fayad LE, Hess MA, Wilder RB, Cabanillas F, Cox JD. Stage III follicular lymphoma: long-term follow-up and patterns of failure. Int J Radiat Oncol Biol Phys 57(3):748-54, 11/2003. PMID: 14529780.
112. Ha CS, Kong JS, Tucker SL, McLaughlin P, Wilder RB, Hess MA, Cabanillas F, Cox JD. Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study. Int J Radiat Oncol Biol Phys 57(2):316-20, 10/2003. PMID: 12957240.
113. Woodward WA, Strom EA, Tucker SL, Katz A, McNeese MD, Perkins GH, Buzdar AU, Hortobagyi GN, Hunt KK, Sahin A, Meric F, Sneige N, Buchholz TA. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys 57(2):336-44, 10/2003. PMID: 12957243.
114. Woodward WA, Strom EA, Tucker SL, McNeese MD, Perkins GH, Schechter NR, Singletary SE, Theriault RL, Hortobagyi GN, Hunt KK, Buchholz TA. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol 21(17):3244-8, 9/2003. PMID: 12947058.
115. Laurent E, Mitchell DL, Estrov Z, Lowery M, Tucker SL, Talpaz M, Kurzrock R. Impact of p210(Bcr-Abl) on ultraviolet C wavelength-induced DNA damage and repair. Clin Cancer Res 9(10 Pt 1):3722-30, 9/2003. PMID: 14506164.
116. Cheung R, Tucker SL, Dong L, Kuban D. Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapy. Int J Radiat Oncol Biol Phys 56(5):1234-40, 8/2003. PMID: 12873666.
117. Nimura Y, Prithivarajsingh S, Ismail SM, Nairn RS, Tucker SL, Allen PK, Stevens CW. Nucleotide excision repair proteins and their importance for radiation-enhanced transfection. Int J Radiat Biol 79(8):663-9, 8/2003. PMID: 14555349.
118. Frank SJ, Forster KM, Stevens CW, Cox JD, Komaki R, Liao Z, Tucker S, Wang X, Steadham RE, Brooks C, Starkschall G. Treatment planning for lung cancer: traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription. Int J Radiat Oncol Biol Phys 56(5):1308-18, 8/2003. PMID: 12873675.
119. Gopal R, Starkschall G, Tucker SL, Cox JD, Liao Z, Hanus M, Kelly JF, Stevens CW, Komaki R. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 56(1):114-20, 5/2003. PMID: 12694829.
120. Gopal R, Tucker SL, Komaki R, Liao Z, Forster KM, Stevens C, Kelly JF, Starkschall G. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 56(1):106-13, 5/2003. PMID: 12694828.
121. Choi HR, Tucker SA, Huang Z, Gillenwater AM, Luna MA, Batsakis JG, El-Naggar AK. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis. Int J Oncol 22(2):409-14, 2/2003. PMID: 12527941.
122. Chronowski GM, Wilder RB, Tucker SL, Ha CS, Younes A, Fayad L, Rodriguez MA, Hagemeister FB, Barista I, Cabanillas F, Cox JD. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy. Int J Radiat Oncol Biol Phys 55(1):36-43, 1/2003. PMID: 12504034.
123. Buchholz TA, Davis DW, McConkey DJ, Symmans WF, Valero V, Jhingran A, Tucker SL, Pusztai L, Cristofanilli M, Esteva FJ, Hortobagyi GN, Sahin AA. Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy. Cancer J 9(1):33-41, Jan-Feb, 1/2003. PMID: 12602766.
124. Chronowski GM, Wilder RB, Tucker SL, Ha CS, Sarris AH, Hagemeister FB, Barista I, Hess MA, Cabanillas F, Cox JD. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease. Cancer 95(12):2534-8, 12/2002. PMID: 12467067.
125. Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M, Herliczek TW, Bacus SS. Cyclin E and survival in patients with breast cancer. N Engl J Med 347(20):1566-75, 11/2002. PMID: 12432043.
126. Buchholz TA, Katz A, Strom EA, McNeese MD, Perkins GH, Hortobagyi GN, Thames HD, Kuerer HM, Singletary SE, Sahin AA, Hunt KK, Buzdar AU, Valero V, Sneige N, Tucker SL. Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 53(4):880-8, 7/2002. PMID: 12095553.
127. Wang J, Buchholz TA, Middleton LP, Allred DC, Tucker SL, Kuerer HM, Esteva FJ, Hortobagyi GN, Sahin AA. Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma. Cancer 94(12):3107-14, 6/2002. PMID: 12115341.
128. Wilder RB, Rodriguez MA, Medeiros LJ, Tucker SL, Ha CS, Romaguera JE, Pro B, Hess MA, Cabanillas F, Cox JD. International prognostic index-based outcomes for diffuse large B-cell lymphomas. Cancer 94(12):3083-8, 6/2002. PMID: 12115338.
129. Buchholz TA, Wu X, Hussain A, Tucker SL, Mills GB, Haffty B, Bergh S, Story M, Geara FB, Brock WA. Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2. Int J Cancer 97(5):557-61, 2/2002. PMID: 11807777.
130. Wilder RB, Romaguera JE, Tucker SL, Ha CS, Hess MA, Cabanillas F, Cox JD. Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma. Cancer 94(3):601-5, 2/2002. PMID: 11857290.
131. Buchholz TA, Tucker SL, Masullo L, Kuerer HM, Erwin J, Salas J, Frye D, Strom EA, McNeese MD, Perkins G, Katz A, Singletary SE, Hunt KK, Buzdar AU, Hortobagyi GN. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol 20(1):17-23, 1/2002. PMID: 11773149.
132. Rosen II, Fischer TA, Antolak JA, Starkschall G, Travis EL, Tucker SL, Hogstrom KR, Cox JD, Komaki R. Correlation between lung fibrosis and radiation therapy dose after concurrent radiation therapy and chemotherapy for limited small cell lung cancer. Radiology 221(3):614-22, 12/2001. PMID: 11719654.
133. Wilder RB, Jones D, Tucker SL, Fuller LM, Ha CS, McLaughlin P, Hess MA, Cabanillas F, Cox JD. Long-term results with radiotherapy for Stage I-II follicular lymphomas. Int J Radiat Oncol Biol Phys 51(5):1219-27, 12/2001. PMID: 11728680.
134. El-Naggar AK, Mao L, Staerkel G, Coombes MM, Tucker SL, Luna MA, Clayman GL, Lippman S, Goepfert H. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn 3(4):164-70, 11/2001. PMID: 11687600.
135. Gopal R, Ha CS, Tucker SL, Khouri IF, Giralt SA, Gajewski JL, Andersson BS, Cox JD, Champlin RE. Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity. Cancer 92(7):1949-58, 10/2001. PMID: 11745270.
136. Buchholz TA, Hill BS, Tucker SL, Frye DK, Kuerer HM, Buzdar AU, McNeese MD, Singletary SE, Ueno NT, Pusztai L, Valero V, Hortobagyi GN. Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy. Cancer J 7(5):413-20, 9/2001. PMID: 11693900.
137. Ha CS, Tucker SL, Blanco AI, Wilder RB, McLaughlin P, Cabanillas F, Cox JD. Hematologic recovery after central lymphatic irradiation for patients with stage I-III follicular lymphoma. Cancer 92(5):1074-9, 9/2001. PMID: 11571717.
138. Stevens CW, Munden RF, Forster KM, Kelly JF, Liao Z, Starkschall G, Tucker S, Komaki R. Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function. Int J Radiat Oncol Biol Phys 51(1):62-8, 9/2001. PMID: 11516852.
139. Ang KK, Jiang GL, Feng Y, Stephens LC, Tucker SL, Price RE. Extent and kinetics of recovery of occult spinal cord injury. Int J Radiat Oncol Biol Phys 50(4):1013-20, 7/2001. PMID: 11429229.
140. Liao Z, Ha CS, Vlachaki MT, Hagemeister F, Cabanillas F, Hess M, Tucker S, Cox JD. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure. Int J Radiat Oncol Biol Phys 50(4):971-7, 7/2001. PMID: 11429225.
141. Wilder RB, Rodriguez MA, Tucker SL, Ha CS, Hess MA, Cabanillas FF, Cox JD. Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas. Int J Radiat Oncol Biol Phys 50(3):743-9, 7/2001. PMID: 11395243.
142. Kurzrock R, Bueso-Ramos CE, Kantarjian H, Freireich E, Tucker SL, Siciliano M, Pilat S, Talpaz M. BCR rearrangement-negative chronic myelogenous leukemia revisited. J Clin Oncol 19(11):2915-26, 6/2001. PMID: 11387365.
143. Krishnamurthy S, Katz RL, Shumate A, Strohlein K, Khanna A, Tucker SL, Raijman I, Lahoti S. DNA image analysis combined with routine cytology improves diagnostic sensitivity of common bile duct brushing. Cancer 93(3):229-35, 6/2001. PMID: 11391612.
144. Buchholz TA, Tucker SL, Erwin J, Mathur D, Strom EA, McNeese MD, Hortobagyi GN, Cristofanilli M, Esteva FJ, Newman L, Singletary SE, Buzdar AU, Hunt KK. Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol 19(8):2240-6, 4/2001. PMID: 11304777.
145. Ha CS, Tucker SL, Lee MS, McLaughlin P, Cabanillas F, Cox JD. The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21). Int J Radiat Oncol Biol Phys 49(3):727-32, 3/2001. PMID: 11172955.
146. Wilder RB, Tucker SL, Ha CS, Rodriguez MA, Hess MA, Cabanillas FF, Cox JD. Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy. Int J Radiat Oncol Biol Phys 49(1):17-22, 1/2001. PMID: 11163493.
147. Schlembach PJ, Wilder RB, Tucker SL, Ha CS, Rodriguez MA, Hess MA, Cabanillas FF, Cox JD. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas. Int J Radiat Oncol Biol Phys 48(4):1107-10, 11/2000. PMID: 11072169.
148. Maor MH, Dubey P, Tucker SL, Shiu AS, Mathur BN, Sawaya R, Lang FF, Hassenbusch SJ. Stereotactic radiosurgery for brain metastases: results and prognostic factors. Int J Cancer 90(3):157-62, 6/2000. PMID: 10900428.
149. Buchholz TA, Tucker SL, Moore RA, McNeese MD, Strom EA, Jhingrin A, Hortobagyi GN, Singletary SE, Champlin RE. Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant. Int J Radiat Oncol Biol Phys 46(2):337-43, 1/2000. PMID: 10661340.
150. Ha CS, Tucker SL, Blanco AI, Cabanillas F, Cox JD. Salvage central lymphatic irradiation in follicular lymphomas following failure of chemotherapy: a feasibility study. Int J Radiat Oncol Biol Phys 45(5):1207-12, 12/1999. PMID: 10613314.
151. El-Naggar AK, Lai S, Tucker SL, Clayman GL, Goepfert H, Hong WK, Huff V. Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma. Oncogene 18(50):7063-9, 11/1999. PMID: 10597307.
152. El-Naggar AK, Dinh M, Tucker SL, Swanson D, Steck K, Vielh P. Numerical chromosomal changes in DNA hypodiploid solid tumors: restricted loss and gain of certain chromosomes. Cytometry 37(2):107-12, 10/1999. PMID: 10486522.
153. El-Naggar AK, Lai S, Clayman GL, Zhou JH, Tucker SL, Myers J, Luna MA, Benedict WF. Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications. Hum Pathol 30(9):1013-8, 9/1999. PMID: 10492034.
154. Steck K, Hunt K, Tucker S, Singletary S, El-Naggar AK. Flow cytometric analysis of Ki-67 in invasive ductal carcinoma of the breast: correlation with tumor and patient characteristics. Oncol Rep 6(4):835-8, 7/1999. PMID: 10373666.
155. Buchholz TA, Hunt KK, Amosson CM, Tucker SL, Strom EA, McNeese MD, Buzdar AU, Singletary SE, Hortobagyi GN. Sequencing of chemotherapy and radiation in lymph node-negative breast cancer. Cancer J Sci Am 5(3):159-64, 5/1999. PMID: 10367172.
156. Lovell M, Lott ST, Wong P, El-Naggar A, Tucker S, Killary AM. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation. Cancer Res 59(9):2182-9, 5/1999. PMID: 10232606.
157. Sarris AH, Kliche KO, Pethambaram P, Preti A, Tucker S, Jackow C, Messina O, Pugh W, Hagemeister FB, McLaughlin P, Rodriguez MA, Romaguera J, Fritsche H, Witzig T, Duvic M, Andreeff M, Cabanillas F. Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival. Ann Oncol 10(4):433-40, 4/1999. PMID: 10370786.
158. Tucker SL. Pitfalls in estimating the influence of overall treatment time on local tumor control. Acta Oncol 38(2):171-8, 1999. PMID: 10227438.
159. Vlachaki MT, Ha CS, Hagemeister FB, Fuller LM, Rodriguez MA, Hess MA, Tucker SL, Cabanillas F, Cox JD. Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1996-1997. Radiology 208(3):739-47, 9/1998. PMID: 9722855.
160. Liao Z, Ha CS, Fuller LM, Hagemeister FB, Cabanillas F, Tucker SL, Hess MA, Cox JD. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors. Int J Radiat Oncol Biol Phys 41(5):1047-56, 7/1998. PMID: 9719114.
161. Jin YT, Kayser S, Kemp BL, Ordonez NG, Tucker SL, Clayman GL, Goepfert H, Luna MA, Batsakis JG, El-Naggar AK. The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer 82(11):2159-65, 6/1998. PMID: 9610695.
162. Geara FB, Komaki R, Tucker SL, Travis EL, Cox JD. Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: evidence for inherent interindividual variation. Int J Radiat Oncol Biol Phys 41(2):279-86, 5/1998. PMID: 9607342.
163. El-Naggar AK, Dinh M, Tucker SL, Gillenwater A, Luna MA, Batsakis JG. Chromosomal and DNA ploidy characterization of salivary gland neoplasms by combined FISH and flow cytometry. Hum Pathol 28(8):881-6, 8/1997. PMID: 9269822.
164. Preti HA, Cabanillas F, Talpaz M, Tucker SL, Seymour JF, Kurzrock R. Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma. Ann Intern Med 127(3):186-94, 8/1997. PMID: 9245223.
165. Tucker SL, Liao ZX, Travis EL. Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys 38(5):1055-66, 7/1997. PMID: 9276372.
166. Travis EL, Liao ZX, Tucker SL. Spatial heterogeneity of the volume effect for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys 38(5):1045-54, 7/1997. PMID: 9276371.
167. Bentzen SM, Tucker SL. Quantifying the position and steepness of radiation dose-response curves. Int J Radiat Biol 71(5):531-42, 5/1997. PMID: 9191898.
168. Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Cleary KR, Ellis LM. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 132(5):541-6, 5/1997. PMID: 9161399.
169. Geara FB, Sanguineti G, Tucker SL, Garden AS, Ang KK, Morrison WH, Peters LJ. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol 43(1):53-61, 4/1997. PMID: 9165137.
170. Geara FB, Glisson BS, Sanguineti G, Tucker SL, Garden AS, Ang KK, Lippman SM, Clayman GL, Goepfert H, Peters LJ, Hong WK. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study. Cancer 79(7):1279-86, 4/1997. PMID: 9083147.
171. Gisslinger H, Kurzrock R, Wetzler M, Tucker S, Kantarjian H, Robertson B, Talpaz M. Apoptosis in chronic myelogenous leukemia: studies of stage-specific differences. Leuk Lymphoma 25(1-2):121-33, 3/1997. PMID: 9130620.
172. Sanguineti G, Geara FB, Garden AS, Tucker SL, Ang KK, Morrison WH, Peters LJ. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys 37(5):985-96, 3/1997. PMID: 9169804.
173. Bouvet M, Babiera GV, Tucker SL, McNeese MD, Singletary SE. Does breast conservation therapy in young women with breast cancer adversely affect local disease control and survival rate: The M. D. Anderson Cancer Center experience. The Breast Journal 3:169-175, 1997.
174. Milross CG, Tucker SL, Mason KA, Hunter NR, Peters LJ, Milas L. The effect of tumor size on necrosis and polarographically measured pO2. Acta Oncol 36(2):183-9, 1997. PMID: 9140436.
175. Tucker SL, Taylor JM. Improved models of tumour cure. Int J Radiat Biol 70(5):539-53, 11/1996. PMID: 8947535.
176. Kitadai Y, Ellis LM, Tucker SL, Greene GF, Bucana CD, Cleary KR, Takahashi Y, Tahara E, Fidler IJ. Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma. Am J Pathol 149(5):1541-51, 11/1996. PMID: 8909244.
177. Duvic M, Lemak NA, Redman JR, Eifel PJ, Tucker SL, Cabanillas FF, Kurzrock R. Combined modality therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 34(6):1022-9, 6/1996. PMID: 8647968.
178. Geara FB, Peters LJ, Ang KK, Garden AS, Tucker SL, Levy LB, Brown BW. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy. Int J Radiat Oncol Biol Phys 35(3):455-62, 6/1996. PMID: 8655367.
179. Felix A, El-Naggar AK, Press MF, Ordonez NG, Fonseca I, Tucker SL, Luna MA, Batsakis JG. Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma. Hum Pathol 27(6):561-6, 6/1996. PMID: 8666365.
180. Winchester DJ, Sahin AA, Tucker SL, Singletary SE. Tubular carcinoma of the breast. Predicting axillary nodal metastases and recurrence. Ann Surg 223(3):342-7, 3/1996. PMID: 8604915.
181. Tucker SL, Geara FB, Peters LJ, Brock WA. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity? Radiother Oncol 38(2):103-13, 2/1996. PMID: 8966222.
182. el-Naggar AK, Dinh M, Tucker S, Luna MA, Goepfert H, Hsu P, Batsakis JG. Genotypic analysis of primary head and neck squamous carcinoma by combined fluorescence in situ hybridization and DNA flow cytometry. Am J Clin Pathol 105(1):102-8, 1/1996. PMID: 8561074.
183. Milross CG, Peters LJ, Hunter NR, Mason KA, Tucker SL, Milas L. Polarographic p02 measurements in mice: Effect of tumor type, site of implantation, and anesthesia. Radiotherapy Oncology Investigations 4:108-14, 1996.
184. el-Naggar AK, Hurr K, Tu ZN, Tucker SL, Swanson D, Hsu PH. Interphase cytogenetics of renal cortical neoplasms. Correlation with DNA ploidy by flow cytometry. Am J Clin Pathol 104(2):141-9, 8/1995. PMID: 7639187.
185. Liao ZX, Travis EL, Tucker SL. Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung. Int J Radiat Oncol Biol Phys 32(5):1359-70, 7/1995. PMID: 7635776.
186. Brock WA, Tucker SL, Geara FB, Turesson I, Wike J, Nyman J, Peters LJ. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int J Radiat Oncol Biol Phys 32(5):1371-9, 7/1995. PMID: 7635777.
187. Suki S, Swan F, Jr, Tucker S, Fritsche HA, Redman JR, Rodriguez MA, McLaughlin P, Romaguera J, Hagemeister FB, Velasquez WS, et al. Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase. Leuk Lymphoma 18(1-2):87-92, 6/1995. PMID: 8580834.
188. Velasquez WS, McLaughlin P, Tucker S, Hagemeister FB, Swan F, Rodriguez MA, Romaguera J, Rubenstein E, Cabanillas F. ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol 12(6):1169-76, 6/1994. PMID: 8201379.
189. Velasquez WS, McLaughlin P, Fuller LM, Allen PK, Tucker SL, Swan F, Jr, Rodriguez MA, Hagemeister FB, Cabanillas FF. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis. Cancer 73(9):2408-16, 5/1994. PMID: 7513251.
190. Obeyesekere MN, Tucker SL, Zimmerman SO. A model for regulation of the cell cycle incorporating cyclin A, cyclin B and their complexes. Cell Prolif 27(2):105-13, 2/1994. PMID: 10465030.
191. Jiang GL, Tucker SL, Guttenberger R, Peters LJ, Morrison WH, Garden AS, Ha CS, Ang KK. Radiation-induced injury to the visual pathway. Radiother Oncol 30(1):17-25, 1/1994. PMID: 8153376.
192. Heaton KM, Rippon MB, el-Naggar A, Tucker SL, Ross MI, Balch CM. Prognostic implications of DNA index in patients with stage III cutaneous melanoma. Am J Surg 166(6):648-52; discussion 652-3, 12/1993. PMID: 8273843.
193. Roberts DB, Travis EL, Tucker SL. Interleukin-1 dose, mouse strain, and end point as they affect protection of mouse jejunum. Radiat Res 135(1):56-63, 7/1993. PMID: 8327661.
194. Hug V, Polyzos A, Tucker S, Thames H. The clonogenic growth of advanced breast tumour lesions adds no value to that of established clinical prognosticators for survival. Br J Cancer 67(2):222-5, 2/1993. PMID: 8431355.
195. Tucker SL, Travis EL. Time course for the hazard of radiation-induced pneumonitis death in mice. Int J Radiat Biol 62(5):627-39, 11/1992. PMID: 1361520.
196. Obeyesekere MN, Tucker SL, Zimmerman SO. Mathematical models for the cellular concentrations of cyclin and MPF. Biochem Biophys Res Commun 184(2):782-9, 4/1992. PMID: 1533516.
197. Thames HD, Schultheiss TE, Hendry JH, Tucker SL, Dubray BM, Brock WA. Can modest escalations of dose be detected as increased tumor control? Int J Radiat Oncol Biol Phys 22(2):241-6, 1992. PMID: 1531477.
198. Tucker SL, Turesson I, Thames HD. Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer 28A(11):1783-91, 1992. PMID: 1389511.
199. Staroselsky AH, Pathak S, Chernajovsky Y, Tucker SL, Fidler IJ. Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma. Cancer Res 51(23, pt 1):6292-8, 12/1991. PMID: 1834329.
200. Singletary SE, Larry L, Tucker SL, Spitzer G. Detection of micrometastatic tumor cells in bone marrow of breast carcinoma patients. J Surg Oncol 47(1):32-6, 5/1991. PMID: 2023419.
201. Litam P, Swan F, Cabanillas F, Tucker SL, McLaughlin P, Hagemeister FB, Rodriguez MA, Velasquez WS. Prognostic value of serum beta-2 microglobulin in low-grade lymphoma. Ann Intern Med 114(10):855-60, 5/1991. PMID: 2014946.
202. Tucker SL, Thames HD, Brown BW, Mason KA, Hunter NR, Withers HR. Direct analyses of in vivo colony survival after single and fractionated doses of radiation. Int J Radiat Biol 59(3):777-95, 3/1991. PMID: 1672365.
203. Velasquez WS, Fuller LM, Jagannath S, Tucker SL, North LB, Hagemeister FB, McLaughlin P, Swan F, Redman JR, Rodriguez MA, et al. Stages I and II diffuse large cell lymphomas: prognostic factors and long-term results with CHOP-bleo and radiotherapy. Blood 77(5):942-7, 3/1991. PMID: 1704805.
204. Tucker SL, Thames HD, Taylor JM. How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics? Radiat Res 124(3):273-82, 12/1990. PMID: 2263727.
205. Singletary SE, Williams NN, Rodeck U, Larry L, Tucker S, Spitzer G, Herlyn M. Transforming growth factor-alpha secretion by epidermal growth factor-dependent human tumor cell lines. Anticancer Res 10(6):1501-5, 11/1990. PMID: 2285223.
206. Eifel PJ, Sampson CM, Tucker SL. Radiation fractionation sensitivity of epiphyseal cartilage in a weanling rat model. Int J Radiat Oncol Biol Phys 19(3):661-4, 9/1990. PMID: 2211212.
207. Tucker SL, Chan KS. The selection of patients for accelerated radiotherapy on the basis of tumor growth kinetics and intrinsic radiosensitivity. Radiother Oncol 18(3):197-211, 7/1990. PMID: 2217868.
208. Tucker SL, Travis EL. Comments on a time-dependent version of the linear-quadratic model. Radiother Oncol 18(2):155-63, 6/1990. PMID: 2367690.
209. Lopez TM, Hagemeister FB, McLaughlin P, Velasquez WS, Swan F, Redman JR, Rodriguez MA, Tucker SL, Silvermintz K, Johnson J. Small noncleaved cell lymphoma in adults: superior results for stages I-III disease. J Clin Oncol 8(4)(4):615-22, 4/1990. PMID: 2313330.
210. Alexanian R, Barlogie B, Tucker S. VAD-based regimens as primary treatment for multiple myeloma. Am J Hematol 33(2):86-9, 2/1990. PMID: 2301376.
211. Bentzen SM, Thames HD, Tucker SL, Smith C. New options in direct analysis of dose-response data. Int J Radiat Biol 57(1):221-5, 1/1990. PMID: 1967290.
212. Tucker SL, Hendry JH. Predicted dose-latency relationships for early- and late-responding hierarchical tissues. Int J Radiat Biol 57(1):163-84, 1/1990. PMID: 1967287.
213. Taylor KM, Jagannath S, Spitzer G, Spinolo JA, Tucker SL, Fogel B, Cabanillas FF, Hagemeister FB, Souza LM. Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. J Clin Oncol 7(12):1791-9, 12/1989. PMID: 2479719.
214. Tucker SL. Expected changes in local tumor control rates resulting from the selective use of accelerated fractionation. Int J Radiat Biol 56(5):739-43, 11/1989. PMID: 2573671.
215. Swan F, Jr, Velasquez WS, Tucker S, Redman JR, Rodriguez MA, McLaughlin P, Hagemeister FB, Cabanillas F. A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels. J Clin Oncol 7(10):1518-27, 10/1989. PMID: 2674337.
216. Velasquez WS, Jagannath S, Tucker SL, Fuller LM, North LB, Redman JR, Swan F, Hagemeister FB, McLaughlin P, Cabanillas F. Risk classification as the basis for clinical staging of diffuse large-cell lymphoma derived from 10-year survival data. Blood 74(2):551-7, 8/1989. PMID: 2752132.
217. Tucker SL, Thames HD, Jr. The effect of patient-to-patient variability on the accuracy of predictive assays of tumor response to radiotherapy: a theoretical evaluation. Int J Radiat Oncol Biol Phys 17(1):145-57, 7/1989. PMID: 2745189.
218. Calabro A, Singletary SE, Tucker S, Boddie A, Spitzer G, Cavaliere R. In vitro thermo-chemosensitivity screening of spontaneous human tumors: significant potentiation for cisplatin but not adriamycin. Int J Cancer 43(3):385-90, 3/1989. PMID: 2925271.
219. Jagannath S, Armitage JO, Dicke KA, Tucker SL, Velasquez WS, Smith K, Vaughan WP, Kessinger A, Horwitz LJ, Hagemeister FB, et al. Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol 7(2):179-85, 2/1989. PMID: 2644397.
220. Terry NH, Tucker SL, Travis EL. Time course of loss of residual radiation damage in murine skin assessed by retreatment. Int J Radiat Biol 55(2):271-83, 2/1989. PMID: 2563399.
221. Singletary SE, Frappaz D, Tucker SL, Larry L, Brock WA, Spitzer G. Epidermal growth factor effect on serum-free growth of primary and metastatic human tumors. Int J Cell Cloning 7(1):59-66, 1/1989. PMID: 2783955.
222. Tucker SL, Zimmerman SO. A nonlinear model of population dynamics containing an arbitrary number of continuous structure variables. SIAM J Appl Math 48(3):549-91, 6/1988.
223. Terry NH, Tucker SL, Travis EL. Residual radiation damage in murine lung assessed by pneumonitis. Int J Radiat Oncol Biol Phys 14(5):929-38, 5/1988. PMID: 3360659.
224. Singletary SE, Tucker SL, Boddie AW, Jr. Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma. Cancer 61(7):1437-40, 4/1988. PMID: 3345495.
225. Velasquez WS, Cabanillas F, Salvador P, McLaughlin P, Fridrik M, Tucker S, Jagannath S, Hagemeister FB, Redman JR, Swan F, et al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood 71(1):117-22, 1/1988. PMID: 3334893.
226. Auber ML, Horwitz LJ, Blaauw A, Khorana S, Tucker S, Woods T, Warmuth M, Dicke KA, McCredie KB, Spitzer G. Evaluation of drugs for elimination of leukemic cells from the bone marrow of patients with acute leukemia. Blood 71(1):166-72, 1/1988. PMID: 2446678.
227. Jagannath S, Reading CL, Dicke KA, Tindle S, Devaraj B, Tucker SL, Spitzer G. Clinical application of Percoll gradient-separated bone marrow. Bone Marrow Transplant 1(3):281-8, 2/1987. PMID: 2901872.
228. Travis EL, Tucker SL. Isoeffect models and fractionated radiation therapy. Int J Radiat Oncol Biol Phys 13(2):283-7, 2/1987. PMID: 3818396.
229. Singletary SE, Baker FL, Spitzer G, Tucker SL, Tomasovic B, Brock WA, Ajani JA, Kelly AM. Biological effect of epidermal growth factor on the in vitro growth of human tumors. Cancer Res 47(2):403-6, 1/1987. PMID: 3491676.
230. Tucker SL. Parameters of radiosensitivity. Radiat Res 108(2):226-9, 11/1986. PMID: 3786679.
231. Thames HD, Jr, Rozell ME, Tucker SL, Ang KK, Fisher DR, Travis EL. Direct analysis of quantal radiation response data. Int J Radiat Biol 49(6):999-1009, 6/1986. PMID: 3486855.
232. Jagannath S, Velasquez WS, Tucker SL, Fuller LM, McLaughlin PW, Manning JT, North LB, Cabanillas FC. Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma. J Clin Oncol 4(6):859-65, 6/1986. PMID: 2423653.
233. Travis EL, Thames HD, Jr, Tucker SL, Watkins TL, Kiss I. Protection of mouse jejunal crypt cells by WR-2721 after small doses of radiation. Int J Radiat Oncol Biol Phys 12(5):807-14, 5/1986. PMID: 3011713.
234. Tucker SL. Is the mean inactivation dose a good measure of cell radiosensitivity? Radiat Res 105(1):18-26, 1/1986. PMID: 3945724.
235. Travis EL, Tucker SL. The relationship between functional assays of radiation response in the lung and target cell depletion. Br J Cancer Suppl 7:304-19, 1986. PMID: 3087402.
236. Singletary SE, Tomasovic B, Spitzer G, Tucker SL, Hug V, Drewinko B. Effects and interactions of epidermal growth factor, insulin, hydrocortisone, and estradiol on the cloning of human tumor cells. Int J Cell Cloning 3(6):407-14, 11/1985. PMID: 3905997.
237. Jagannath S, Velasquez WS, Tucker SL, Manning JT, McLaughlin P, Fuller LM. Stage IV diffuse large-cell lymphoma: a long-term analysis. J Clin Oncol 3(1):39-47, 1/1985. PMID: 3965633.
238. Tucker SL. Tests for the fit of the linear-quadratic model to radiation isoeffect data. Int J Radiat Oncol Biol Phys 10(10):1933-9, 10/1984. PMID: 6490423.
239. Tucker SL, Thames HD, Jr. Flexure dose: the low-dose limit of effective fractionation. Int J Radiat Oncol Biol Phys 9(9):1373-83, 9/1983. PMID: 6885550.
240. Tucker SL, Thames HD, Jr. Optimal design of multifraction assays of colony survival in vivo. Radiat Res 94(2):280-94, 5/1983. PMID: 6856774.
241. Dicke KA, Tindle SE, Davis FM, Jagannath S, Tucker S, Lilien M, van Leeuwen P, Verma DS, Vellekoop L. Leukemic cell colony formation in soft agar by bone marrow cells and peripheral blood cells from untreated acute leukemia patients. Exp Hematol 11(4):341-50, 4/1983. PMID: 6341080.
242. Tucker SL, Withers HR, Mason KA, Thames HD, Jr. A dose-surviving fraction curve for mouse colonic mucosa. Eur J Cancer Clin Oncol 19(3):433-7, 3/1983. PMID: 6683181.

Invited Articles

1. Buchholz TA, Tucker SL, Katz A, McNeese MD, Strom EA, Perkins GH, Buzdar AU, Kuerer HM, Hunt KK, Singletary SE, Sahin AA, Thames HD, Meric F, Masullo L, Hortobagyi GN. Factors Predictive For Local-Regional Recurrence After Neoadjuvant Chemotherapy and Mastectomy:Implications for Radiation Treatment. Am J Onc Rev 1:13-6, 2002.
2. Thames HD, Tucker SL, Rasmussen SL, McLarty JW. Regression methods in clinical radiobiology. Proceedings of the RPM Topical Symposium Meeting, 1984.
3. Albertson M, Bollobas B, Tucker S. The independence ratio and maximum degree of a graph. Proceedings of the Southeastern Conference on Combinatorics, Graph Theory, and Computing:43-50, 1976.

Editorials

1. Brock WA, Tucker SL. In vitro radiosensitivity and normal tissue damage. Radiother Oncol 55(2):93-4, 5/2000. PMID: 10799719.

Abstracts

1. Tsai J, Lindberg ME, Garden AS, Sturgis EM, Hofstede TM, Tucker SL, Dong L. Osteoradionecrosis and Radiation Dose to the Mandible in Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys 78(3/ Supplement 1):S153, 11/2010.

Book Chapters

1. Tucker SL. Modeling the probability of tumor cure after fractionated radiotherapy. In: Proceedings of the Conference on Mathematical Models in Medical and Health Sciences. Ed(s) MA Horn, G Simonett, G Webb. Vanderbilt University: Nashville, TN, 1999.
2. Travis EL, Tucker SL. The volume effect for radiation pneumonitis in mouse lung. In: Volume & Kinetics in Tumor Control & Normal Tissue Complications. Ed(s) BR Paliwal, JF Fowler, DE Herbert, MP Mehta. Medical Physics Publishing: Madison, WI, 5-17, 1998.
3. Tucker SL. The volume effect in lung. In: Experimental Radiotherapy and Clinical Radiobiology. 6. Ed(s) H-P Beck-Bornholdt and M Baumann, 3-7, 1997.
4. Obeyesekere MN, Tucker SL, Zimmerman SO. Mathematical models for regulation of the cell cycle via the concentrations of cellular proteins. In: Mathematical Population Dynamics: Analysis of Heterogeneity. Volume Two: Carcinogenesis and Cell & Tumor Growth. Two. Ed(s) O Arino, D Axelrod, M Kimmel. Wuerz Publishing Ltd: Winnipeg, 171-82, 1995.
5. Tucker SL. Inference from tumor recurrence data regarding the range of individual differences in tumor-cell radiosensitivity and proliferation rate. In: Prediction of Response in Radiation Therapy. Radiosensitivity and Repopulation. Ed(s) B Paliwal, JF Fowler, D Herbert, and TJ Kinsella. American Institute of Physics, Inc: New York, NY, 53, 1993.
6. Tucker SL, Thames HD, Turesson I. Individual variation in the radiosensitivity of human skin. In: Radiation Research: A Twentieth-Century Perspective. Volume 1. Academic Press, Inc, 1991.
7. Peters, LJ, Brock, WA, Tucker, SL. Clinical Correlations Between In Vitro Radiosensitivity and Local Regional Control of Head and Neck Cancers. In: Progress In Radio-Oncology IV. Ed(s) KH Kaercher, 115-119, 1989.
8. Tucker SL, Zimmerman SO. The Relationship Between Cell Loss and Recruitment for Stable Age-Structured Populations of Cycling and Non-Cycling Cells. IMACS Annals of Computing and Applied Mathematics, IMACS Transactions on Scientific Computing, 12th IMACS World Congress, Paris, 1988. In: Biomedical Systems Modeling and Simulation. 5. Ed(s) J Eisenfeld and DL Levine. J. C. Baltzer AG, 13-8, 1989.
9. Tucker SL, Thames HD. The Relative Role of Intrinsic Radiosensitivity in the Prediction of Tumor Response to Treatment. In: Prediction Of Response In Radiation Therapy. Part 2: Analytical Models and Modeling. Ed(s) BR Paliwal, JF Fowler, DE Herbert, TJ Kinsella, CG Orton. American Institute of Physics, Inc: New York, NY, 739-50, 1989.
10. Jagannath S, Armitage JO, Dicke KA, Tucker SL, Velasquez WS, Smith K, Vaughan WP, Kessinger A, Horwitz LJ, Hagemeister FB, Cabanillas F, Spitzer G. Timing of High Dose CBV and Autologous Bone Marrow Transplantation in the Management of Relapsed or Refractory Hodgkin's Disease. In: Autologous Bone Marrow Transplantation. Ed(s) KA Dicke, G Spitzer, S Jagannath, MJ Evinger-Hodges. The University of Texas M. D. Anderson Cancer Center: Houston, TX, 275-83, 1989.
11. Tucker SL, Zimmerman SO. Models of Cellular Regulation in Normal and Neoplastic Tissues. In: Proceedings of the 12th IMACS World Congress on Scientific Computation. 4. World Congress on Scientific Computation, 134-137, 1988.
12. Tucker SL. Cell Population Models with Continuous Structure Variables. In: Cancer Modeling. Ed(s) JR Thompson and BW Brown. Marcel Dekker, Inc: New York, NY, 181-213, 1987.
13. Vellekoop L, Spitzer G, Tucker SL, Dicke KA. Predictive Value of Progenitor Cell Assays for Time of Hematopoietic Recovery after Autologous Bone Marrow Transplantation. In: Autologous Bone Marrow Transplantation. Ed(s) KA Dicke, G Spitzer, and AR Zander. University of Texas, 477-480, 1985.
14. Velasquez WS, Jagannath S, Tucker S, Manning J, McLaughlin P, Oh KK, Hagemeister FB, Fuller LM. Prognostic Factors for Stage III and Stage IV Diffuse Large Cell Lymphoma: Long Term Follow-up. In: Hodgkin's Disease and Non-Hodgkin's Lymphoma: New Prespectives in Immuno-Pathology, Diagnosis and Treatment. Ed(s) RJ Ford, LM Fuller and FB Hagemeister. Raven Press: New York, NY, 357-376, 1984.

Letters to the Editor

1. Komaki R, Liao Z, Liu H, Tucker S, Rice D. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma:In regard to Allen et al. Int J Radiat Oncol Biol Phy 66(5):1595-6, 2006.
2. Keyomarsi K, Tucker SL, Bedrosian I. Cyclin E is a more powerful predictor of breast cancer outcome than proliferation. Nat Med 9(2)(2):152, 2003. PMID: 12563321.
3. Bentzen SM, Tucker SL. Individualization of radiotherapy dose prescriptions by means of an in vitro radiosensitivity assay. Radiotherapy & Oncology 46(2):216-8, 1998. PMID: 9510051.
4. Geara FB, Tucker SL, Peters LJ. In response to comments by Dr. N.G. Burnet. International Journal of Radiation Oncology Biology Physics 38:1137-8, 1997.
5. Taylor JMG, Tucker SL, Thames HD. The Probability of Tumor Cure: Response to Comments by Dr. Yakovlev. Radiation Research 134:121-2, 1993.
6. Tucker SL. Predicting Normal Tissue Injury in Radiation Therapy. International Journal of Radiation Oncology Biology Physics 21:1391-2, 1991.
7. Tucker SL. Testing the Fit of the LQ Model to Isoeffect Data. International Journal of Radiation Oncology Biology Physics 12:291-2, 1986.

Last updated: 7/17/2013